Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Total Liabilities (2013 - 2026)

Scynexis' (SCYX) quarterly Total Liabilities came in at $8.0 million in Q2 2026, down 50.45% on a YoY basis from $16.2 million in Q2 2025, and down 77.86% quarter-over-quarter from $36.3 million in Q1 2026.

Analysis

Scynexis (SCYX) Total Liabilities (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Total Liabilities for 14 consecutive years, with $8.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Liabilities fell 50.45% year-over-year to $8.0 million; the trailing twelve-month figure through Jun 2026 stood at $8.0 million (down 50.45% YoY), and the FY2025 full-year result was $9.7 million, down 72.86% from the prior year.
  • Total Liabilities eased to $8.0 million in Q2 2026 per SCYX's latest filing, from $36.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $100.2 million in Q1 2023 and bottomed at $8.0 million in Q2 2026.
  • Historically, Total Liabilities has averaged $49.2 million across 5 years, with a median of $45.8 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Total Liabilities slumped 72.86% in 2025, then surged 108.93% in 2026.
  • Over 5 years, Total Liabilities stood at $84.6 million in 2022, then slumped by 34.44% to $55.4 million in 2023, then plunged by 35.86% to $35.6 million in 2024, then slumped by 72.86% to $9.7 million in 2025, then retreated by 16.69% to $8.0 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $8.0 million, $36.3 million, and $9.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.62 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 384.62 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 8.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.04 Mn
Mar 31, 2026 36.32 Mn
Dec 31, 2025 9.65 Mn
Sep 30, 2025 14.64 Mn
Jun 30, 2025 16.23 Mn
Mar 31, 2025 17.38 Mn
Dec 31, 2024 35.57 Mn
Sep 30, 2024 40.51 Mn
Jun 30, 2024 47.40 Mn
Mar 31, 2024 44.15 Mn
Dec 31, 2023 55.45 Mn
Sep 30, 2023 56.56 Mn
Jun 30, 2023 61.78 Mn
Mar 31, 2023 100.21 Mn
Dec 31, 2022 84.58 Mn
Sep 30, 2022 95.08 Mn
Jun 30, 2022 90.13 Mn
Mar 31, 2022 72.64 Mn
Dec 31, 2021 78.58 Mn
Sep 30, 2021 72.27 Mn